AnaptysBio, Inc. Common Stock (ANAB) is a publicly traded Healthcare sector company. As of November 10, 2026, ANAB trades at $48.37 with a market cap of $1.43B and a P/E ratio of -49.21. ANAB moved +0.93% today. Year to date, ANAB is +7.60%; over the trailing twelve months it is +42.33%. Its 52-week range spans $15.40 to $73.30. Analyst consensus is strong buy with an average price target of $77.40. Rallies surfaces ANAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ANAB, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $48.37 |
| Market Cap | $1.43B |
| P/E Ratio | -49.21 |
| EPS | $-0.94 |
| Dividend Yield | 0.00% |
| 52-Week High | $73.30 |
| 52-Week Low | $15.40 |
| Volume | 201.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $232.39M |
| Net Income | $-26.79M |
| Gross Margin | 0.00% |
6 analysts cover ANAB: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $77.40.